Navigation Links
Patients who Participated in Pleio GoodStart(TM) Refilled 30% Sooner and 40% More, Averaging 2 Additional Rx Refills per Patient
Date:10/26/2009

PHILADELPHIA, Oct. 26 /PRNewswire/ -- Pleio Health Support Systems, Inc. (Pleio) announces updated results of the Pleio GoodStart(TM) medication adherence program. Retrospective analysis of retail pharmacy prescription data from 1,776 patients taking a chronic cardiovascular medication between May 2008 and September 2009, revealed that Pleio GoodStart(TM) had a highly significant impact on medication adherence, resulting in patients refilling an average of two additional 30-day prescriptions during their initial 9-month period on the medication (p<0.001).

Data also showed that patients who participated in the GoodStart(TM) program refilled their prescriptions an average of ten days sooner than control group participants. Collectively, these data demonstrate a significant, sustained improvement in patient medication adherence with the Pleio GoodStart(TM) program.

"Improving people's experience with new prescription medications involves many disciplines. Pleio's technology, pharmacy and manufacturer partners are equally dedicated to improving the patient experience with new prescriptions. These results show that when elderly patients are carefully listened to, stimulated in language they can relate to, and empowered with performance support, adherence challenges are easily overcome."

Pleio GoodStart connects physicians, patients, pharmacies, families and pharmaceutical manufacturers toward their common goal of improved patient adherence. Physicians gain the assurance that their patients will be well-supported and that future patient appointments can be more effective. Pharmacies are provided a new perspective on C&P through training and feedback on patient progress. Patients receive unprecedented interest in their welfare throughout the medication adoption phase, with up to 75 contacts during their first 100 days on therapy. Family and friend support is stimulated through awareness of the issue of adherence and thei
'/>"/>

SOURCE Pleio Health Support Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
2. Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
3. Patients Receiving High Radiation at Cedars Sinai File Class Action Lawsuit
4. Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients
5. Patients Taking VIMOVO(TM) Showed a Decrease in Incidence of NSAID-Associated Ulcers
6. ULORIC(R) (febuxostat) Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout
7. U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
8. Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences
9. New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met(R) (pioglitazone HCl and metformin HCl) as Initial Therapy Compared to Either Component Alone
10. Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available
11. Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... -- Hutchison China MediTech Limited ("Chi-Med") ... ("HMP"), its drug R&D subsidiary, successfully achieved the ... of fruquintinib in patients with advanced non-squamous non-small ... .  The top-line results demonstrated that the ... endpoint of progression free survival ("PFS"). ...
(Date:9/3/2015)... With a population of more than 1 ... also its single largest potential market for goods and ... all major world economies in the average rate of ... health expenditures. As an in vitro diagnostics (IVD) market, ... United States, western European countries, and Japan. China represents ...
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 ... successfully used to save millions of lives across globe. ... the Kingdom of Saudi Arabia . ... raw material suppliers, government agencies and regulatory bodies. The ... been studied from two perspectives: by products and by ...
Breaking Medicine Technology:Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13Saudi Arabia Defibrillators Market: & Advanced Life Support Defibrillators; End Users; Industry Analysis, Size, Volume, Growth, Trends and Forecast 2014 - 2020 2
... 15, 2012 For the 35 million people ... new, fast, effective approach to treatment is now ... light, radiofrequency and ultrasound aesthetic and medical devices, ... newest innovation for the Harmony(XL) multi-application, multi-technology platform, ...
... BARCELONA, Spain, March 15, 2012 Grifols (MCE:GRF, MCE:GRF.P ... largest plasma product manufacturer and a pioneer in the ... to both scientific and social development, has acquired 51% ... the viability of its projects and the future of ...
Cached Medicine Technology:New Nail Fungus Approach Receives FDA Clearance 2Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 2Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 3Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 4Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 5Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 6Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 7Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 8
(Date:9/4/2015)... ... September 04, 2015 , ... According to an article ... the American Dental Association presented data showing that it is safe for pregnant women ... pregnant women that had undergone local anesthesia with a group that hadn’t, researchers were ...
(Date:9/4/2015)... ... , ... The Schmidt National Law Group filed an Essure® lawsuit against Bayer ... Law Group, a leading firm in mass-tort litigation, has filed a lawsuit in the ... and other Bayer affiliates for injuries alleged to have been caused by her Essure® ...
(Date:9/4/2015)... , ... September 04, 2015 , ... After wearing the ... desperate need of new apparel. In an effort to assist the team, the Jones ... launched a charity drive to raise funds for the new uniforms. , As is ...
(Date:9/4/2015)... ... 2015 , ... Keeping mold top of mind is important when considering indoor ... can grow anywhere - on carpet, clothing, food, paper, and even in places you ... in the home is key to preventing mold growth, which if exposed to can ...
(Date:9/4/2015)... ... ... are looking for a quick and convenient way to produce a hot remedy for colds. ... a quick and simple way to brew a hot cup of cold remedy when desired. ... they enhance comfort and health. The invention features a novel design that is lightweight, compact ...
Breaking Medicine News(10 mins):Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2
... (NIH) will commit roughly $60 million from American Recovery ... meet objectives set forth earlier this year by a ... largest funding opportunity for research on autism spectrum disorders ... represents a surge in NIH,s commitment to finding the ...
... RICHMOND, Va. (March 24, 2009) Virginia Commonwealth University ... with hearing loss actually re-route the sense of touch ... the study, published online in the Early Edition of ... the week of March 23, the team reported ...
... leading provider of autism services shares events that raise ... Autism is the fastest-growing developmental disability in the ... a child is diagnosed with an autism spectrum disorder. ... and AIDS combined. It is one of our community,s ...
... LCG Associates, a national investment consulting firm, ... L. Bentley, CFA, CAIA.LCG,s ownership provides significant incentive ... the consulting industry. LCG rewards ownership in ... commitment to excellence and honesty.LCG Associates, Inc. provides ...
... School Children , ... St. Cloud, Minn. (Vocus) March ... dental program to St. Cloud Area School District 742 public elementary ... health of low-income and uninsured children. Smiles Across Minnesota provides children ...
... Is Urgent; Among Seniors with Diabetes, Half Are Unaware; Medicare,s ... City Councilors Nancy White, RN, Charles Jones, and Ed ... Macon area seniors to learn more about their personal risk ... (MDSP) in Macon before a crowd gathered in front of ...
Cached Medicine News:Health News:NIH will use $60 million in Recovery Act funds to support strategic autism research 2Health News:NIH will use $60 million in Recovery Act funds to support strategic autism research 3Health News:April is Autism Awareness Month 2Health News:April is Autism Awareness Month 3Health News:Smiles Across Minnesota Expands Program to St. Cloud 2Health News:Smiles Across Minnesota Expands Program to St. Cloud 3Health News:Smiles Across Minnesota Expands Program to St. Cloud 4Health News:City Councilors Nancy White, RN, Charles Jones, and Ed DeFore Launch Medicare Diabetes Screening Project in Macon 2Health News:City Councilors Nancy White, RN, Charles Jones, and Ed DeFore Launch Medicare Diabetes Screening Project in Macon 3
... IMMULITE 1000 assays are designed ... and IMMULITE 1000, continuous random ... simplicity in both design and ... found in a wide variety ...
The C-Reactive Protein (CRP) assay is used for the quantitative analysis of C-reactive protein in human serum and plasma. Kit is for use with the Abbot Laboratories Aeroset, ARCHITECT c8000 or ARCHI...
... windows for the laboratory in flexibility, communication, ... from one function to another. You can ... add a new patient record simultaneously. LabDAQ ... of all the open functions and to ...
... Biotech, Inc. is illuminating the way for ... enumeration. The Color QCount™ utilizes the latest ... capture full color sample images. Its ease ... quickly and efficiently. This extraordinary time reduction ...
Medicine Products: